The investigators seek to test whether incorporating the scheduled dosing of a bisacodyl 10
mg rectal suppository every other day improves bowel-related symptoms in patients with
multiple sclerosis. Patients will be randomized to receive either a placebo suppository or
bisacodyl suppository dosed every other day for 4 weeks.